Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PBYI compared with EBS: revenue, margins and what each company keeps, and the suppliers and customers both name
PBYI
Puma Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
EBS
Emergent BioSolutions Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PBYI
Puma Biotechnology, Inc.
vs
EBS
Emergent BioSolutions Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PBYI, solid
EBS, dashed
PBYI
Puma Biotechnology, Inc.
Change
10.42
· pre 10.43
· delayed
Mkt cap
$538.9M
Revenue
$57M
Q2 FY26
Revenue
$228M
FY25
EBS
Emergent BioSolutions Inc.
Change
6.79
· pre 6.79
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$349.2M
Revenue
$234M
Q2 FY26
Revenue
$743M
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
PBYI
Puma Biotechnology, Inc.
vs
EBS
Emergent BioSolutions Inc.
10.42
pre 10.43
delayed
Price
6.79
pre 6.79
delayed
$538.9M
Mkt cap
$349.2M
Q2 FY26
$57M
Revenue
$234M
Q2 FY26
FY25
$228M
Revenue
$743M
FY25
Change
Change
PBYI
10.42
vs
EBS
6.79
Pre-market
Oct 30 '26
delayed